Italia markets open in 20 minutes

ResMed Inc. (0KW4.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
267,52+14,52 (+5,74%)
Alla chiusura: 05:36PM GMT
Schermo intero
Chiusura precedente253,00
Aperto267,52
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno267,52 - 267,52
Intervallo di 52 settimane267,52 - 267,52
Volume6
Media VolumeN/D
Capitalizzazione37,627B
Beta (5 anni mensile)0,31
Rapporto PE (ttm)78,41
EPS (ttm)3,41
Prossima data utili26 gen 2022 - 31 gen 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors

    Desney Tan Desney Tan, ResMed board director John Hernandez, ResMed board director John Hernandez, ResMed board director Tan is vice president and managing director of Microsoft’s Health and Life Science R&D Hernandez is Google’s head of clinical research, health economics, and outcomes researchBoth leaders’ digital health experience at world-leading tech firms can help oversee ResMed’s strategy to improve 250 million lives in 2025ResMed’s board increases from eight to ten directors SAN DIEGO, N

  • GlobeNewswire

    ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference

    SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Wednesday, November 10, 2021, beginning at approximately 1:00 p.m. (Eastern Standard Time) via video webcast. More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay will be av

  • GlobeNewswire

    ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022

    Year-over-year revenue grows 20%, operating profit up 21%, non-GAAP operating profit up 18% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended September 30, 2021. First Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 20% to $904.0